Abdominal obesity is defined by a waist circumference cut-off greater than 102 cm for men and 88 cm for women, and hyperglycemia is defined by a fasting plasma glucose greater than 5.6 mmol/L (100 mg/dL) and/or the existence of a symptomatic treatment (such as metformin or insulin in the most advanced forms). This evidence concerns the gene INS and Abdominal obesity.